Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5

Science

Volumn 275, Issue 5304, 1997, Pages 1320-1323

  Bergelson, Jeffrey M ^a   Cunningham, Jennifer A ^a   Droguett, Gustavo ^b   Kurt Jones, Evelyn A ^a   Krithivas, Anita ^a   Hong, Jeong S ^c   Horwitz, Marshall S ^b   Crowell, Richard L ^d   Finberg, Robert W ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; VIRUS RECEPTOR; VIRUS VECTOR;

ADENOVIRUS 2; ADENOVIRUS 5; ANIMAL CELL; ARTICLE; CHO CELL; CONTROLLED STUDY; COXSACKIE VIRUS B; GENE TRANSFER; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ISOLATION; VIRUS ADSORPTION; VIRUS INFECTION;

ADENOVIRUSES, HUMAN; AMINO ACID SEQUENCE; ANIMALS; CHO CELLS; CRICETINAE; CYTOPATHOGENIC EFFECT, VIRAL; ENTEROVIRUS B, HUMAN; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HELA CELLS; HUMANS; MOLECULAR SEQUENCE DATA; RECEPTORS, VIRUS; SEQUENCE ALIGNMENT; TRANSFECTION; VIRUS REPLICATION;

ADENOVIRIDAE; ANIMALIA; COXSACKIEVIRUS; CRICETINAE; HUMAN ADENOVIRUS TYPE 2; HUMAN ADENOVIRUS TYPE 5; HUMAN ENTEROVIRUS B;

EID: 0031052263     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.275.5304.1320     Document Type: Article

References (47)

1. M. S. Horwitz, in Virology, B. N. Fields, D. M. Knipe, P. M. Howley, Eds. (Lippincott-Raven, Philadelphia, 1996), vol. 2, pp. 2149-2171.
2. A. B. Martin et al., Circulation 90, 330 (1994).
3. E. J. Kremer and M. Perricaudet, Br. Med. Bull. 51, 31 (1995).
4. J. L. Melnick, in Virology, B. N. Fields, D. M. Knipe, P. M. Howley, Eds. (Lippincott-Raven, Philadelphia, 1996), vol. 2, pp. 655-712.
5. C. W. Imrie, J. C. Ferguson, R. G. Sommerville, Gut 18, 53 (1977).
6. 6. J. W. Yoon, M. Austin, T. Onodera, A. L. Notkins, N. Engl. J. Med. 300, 1173 (1979); G. B. Clements, D. N. Galbraith, K. W. Taylor, Lancet 346, 221 (1995).
7. J. W. Yoon, M. Austin, T. Onodera, A. L. Notkins, N. Engl. J. Med. 300, 1173 (1979); G. B. Clements, D. N. Galbraith, K. W. Taylor, Lancet 346, 221 (1995).
8. N. R. Grist and D. Reid, in Viral Infections of the Heart, J. Banatvala, Ed. (Arnold, London, 1993), pp. 23-31; M. C. Savoia and M. N. Oxman, in Principles and Practice of Infectious Diseases, G. M. Mandell, J. E. Bennet, R. Dolin, Eds. (Churchill Livingstone, New York, 1995), vol. 1, pp. 799-813.
9. N. R. Grist and D. Reid, in Viral Infections of the Heart, J. Banatvala, Ed. (Arnold, London, 1993), pp. 23-31; M. C. Savoia and M. N. Oxman, in Principles and Practice of Infectious Diseases, G. M. Mandell, J. E. Bennet, R. Dolin, Eds. (Churchill Livingstone, New York, 1995), vol. 1, pp. 799-813.
10. J. E. Mapoles, D. L. Krah, R. L. Crowell, J. Virol. 55, 560 (1985); K.-H. L. Hsu, S. Paglini, B. Alstein, R. L. Crowell, in New Aspects of Positive-Strand RNA Viruses, M. Brinton and F. Heinz, Eds. (American Society for Microbiology, Washington, DC, 1990), pp. 271-277.
11. J. E. Mapoles, D. L. Krah, R. L. Crowell, J. Virol. 55, 560 (1985); K.-H. L. Hsu, S. Paglini, B. Alstein, R. L. Crowell, in New Aspects of Positive-Strand RNA Viruses, M. Brinton and F. Heinz, Eds. (American Society for Microbiology, Washington, DC, 1990), pp. 271-277.
12. K.-H. L. Hsu, K. Lonberg-Holm, B. Alstein, R. L. Crowell, J. Virol. 62, 1647 (1988).
13. HeLa S3 cells were homogenized in 10 mM tris buffer (pH 7.6) containing 2.5 mM EDTA, 2.5 mM EGTA, and protease inhibitors. After centrifugation of the homogenate at 145,000g for 90 min, the pellet was homogenized in the same buffer containing 150 mM NaCl. Triton X-100 was added to a final concentration of 1%, and proteins were extracted for 3 hours. Insoluble material was removed by recentrifugation, then the extract was pre-cleared with protein G-Sepharose to which irrelevant antibodies had been covalently coupled. Affinity chromatography was performed by pumping the pre-cleared extract through a column containing mAb RmcB coupled to protein G-Sepharose. The column was washed extensively, then bound protein was eluted in 50 mM diethylamine (pH 11.5).
14. Fractions containing the 46-kD protein were repuritied by electrophoresis in a 10% SDS-polyacrylamide gel and stained as described [J. Rosenfeld, J. Capdevielle, J. C. Guillemot, P. Ferrara, Anal. Biochem. 203, 173 (1992)]. The protein bands were excised. After in-gel digestion with trypsin, the sequences of four peptides were determined at the Harvard Microchemistry Facility by collisionally activated dissociation on a Finnigan TSQ 7000 triple quadrupole mass spectrometer.
15. A corresponding expressed sequence tag (EST) cDNA (emb F05145; IMAGE Consortium Clone ID 25001) isolated from an infant brain library [G. G. Lennon, C. Auffray, M. Polymeropoulos, M. B. Soares, Genomics 33, 151 (1996)] was identified in the dbEST database and used to screen a pcDNAI HeLa cell library (Invitrogen, San Diego, CA). The longest cDNA insert [2437 base pairs (bp)] was sequenced and contained a short upstream untranslated region, a consensus sequence for translation initiation [M. Kozak, Nucleic Acids Res. 15, 8125 (1987)], a 1095-bp open reading frame, a 1259-bp downstream untranslated region, and a polyadenylate tail.
16. A corresponding expressed sequence tag (EST) cDNA (emb F05145; IMAGE Consortium Clone ID 25001) isolated from an infant brain library [G. G. Lennon, C. Auffray, M. Polymeropoulos, M. B. Soares, Genomics 33, 151 (1996)] was identified in the dbEST database and used to screen a pcDNAI HeLa cell library (Invitrogen, San Diego, CA). The longest cDNA insert [2437 base pairs (bp)] was sequenced and contained a short upstream untranslated region, a consensus sequence for translation initiation [M. Kozak, Nucleic Acids Res. 15, 8125 (1987)], a 1095-bp open reading frame, a 1259-bp downstream untranslated region, and a polyadenylate tail.
17. - CHO cells with CAR cDNA and a plasmid encoding dihydrofolate reductase, selection of transfectants in nucleoside-free medium, and fluorescence-activated cell sorting with RmcB were performed as described for transfection with the integrin α2 subunit (14).
18. J. M. Bergelson et al., J. Virol. 67, 6847 (1993).
19. Murine CAR cDNA [European Molecular Biology Laboratory (EMBL) accession number Y10320] was obtained from a mouse liver cDNA library (Gibco-BRL).
20. J. M. Bergelson, M. P. Shepley, B. M. C. Chan, M. E. Hemler, R. W. Finberg, Science 255, 1718 (1992).
21. J. M. Bergelson, unpublished results.
22. R. L. Crowell, in Ninth Miles International Symposium: Cell Membrane Receptors for Viruses, Antigens and Antibodies, Polypeptide Hormones and Small Molecules, R. F. Beers and E. G. Bassett, Eds. (Raven, New York, 1976), pp. 179-202; _ and R. P. Tomko, in Cellular Receptors for Animal Viruses, E. Wimmer, Ed. (Cold Spring Harbor Laboratory Press, Plainview, NY, 1994), pp. 75-99.
23. R. L. Crowell, in Ninth Miles International Symposium: Cell Membrane Receptors for Viruses, Antigens and Antibodies, Polypeptide Hormones and Small Molecules, R. F. Beers and E. G. Bassett, Eds. (Raven, New York, 1976), pp. 179-202; _ and R. P. Tomko, in Cellular Receptors for Animal Viruses, E. Wimmer, Ed. (Cold Spring Harbor Laboratory Press, Plainview, NY, 1994), pp. 75-99.
24. CAR cDNA sequences are represented in ESTs derived from human brain and pancreatic islet cells. When used to probe a human tissue Northern (RNA) blot (Clontech), CAR cDNA hybridized most strongly to RNA from the heart, brain, and pancreas, which is consistent with the known tropism of coxsackie B viruses for these tissues. Faint hybridization to liver and lung RNA was also detected, but none to RNA from the kidney, placenta, or skeletal muscle.
25. J. M. Bergelson et al., J. Virol. 69, 1903 (1995); D. R. Shafren et al., ibid., p. 3873.
26. J. M. Bergelson et al., J. Virol. 69, 1903 (1995); D. R. Shafren et al., ibid., p. 3873.
27. J. K. Muckelbauer et al., Structure 3, 653 (1995).
28. L. Philipson, K. Lonberg-Holm, U. Pettersson, J. Virol. 2, 1064 (1968); C. Defer, M.-T. Belin, M. L. Caillet-Boudin, P. Boulanger, ibid. 64, 3661 (1990).
29. L. Philipson, K. Lonberg-Holm, U. Pettersson, J. Virol. 2, 1064 (1968); C. Defer, M.-T. Belin, M. L. Caillet-Boudin, P. Boulanger, ibid. 64, 3661 (1990).
30. L. J. Henry, D. Xia, M. E. Wilke, J. Deisenhofer, R. D. Gerard, ibid. 68, 5239 (1994); N. Louis, P. Fender, A. Barge, P. Kitts, J. Chroboczek, ibid., p.4104; S. C. Stevenson, M. Rollence, B. White, L. Weaver, A. McClelland, ibid. 69, 2850 (1995).
31. L. J. Henry, D. Xia, M. E. Wilke, J. Deisenhofer, R. D. Gerard, ibid. 68, 5239 (1994); N. Louis, P. Fender, A. Barge, P. Kitts, J. Chroboczek, ibid., p.4104; S. C. Stevenson, M. Rollence, B. White, L. Weaver, A. McClelland, ibid. 69, 2850 (1995).
32. L. J. Henry, D. Xia, M. E. Wilke, J. Deisenhofer, R. D. Gerard, ibid. 68, 5239 (1994); N. Louis, P. Fender, A. Barge, P. Kitts, J. Chroboczek, ibid., p.4104; S. C. Stevenson, M. Rollence, B. White, L. Weaver, A. McClelland, ibid. 69, 2850 (1995).
33. K. Lonberg-Holm, R. L. Crowell, L. Philipson, Nature 259, 679 (1976).
34. M. Longiaru and M. S. Horwitz, Mol. Cell. Biol. 1, 208 (1981); R. L. Radna, B. Foellmer, L. A. Feldman, U. Francke, H. L. Ozer, Virus Res. 8, 277 (1987).
35. M. Longiaru and M. S. Horwitz, Mol. Cell. Biol. 1, 208 (1981); R. L. Radna, B. Foellmer, L. A. Feldman, U. Francke, H. L. Ozer, Virus Res. 8, 277 (1987).
36. Y. Manome et al., Nature Med. 2, 567 (1996).
37. Lysates were prepared and assayed with the use of reagents provided in the Promega β-Gal enzyme assay system. After addition of development buffer containing o-nitrophenyl β-D-galactopyranoside, absorbance at 405 nm was measured at 20-s intervals in a kinetic microplate reader (Molecular Devices) and maximum V was calculated for each sample. Cells infected at 1 plaque-forming unit (PFU) per cell gave the following values (milli-optical density units per minute ± SD for triplicate samples): CHO-al 2, 0.01 ± 0.01; HeLa, 0.16 ± 0.05; and CHO-CAR, 1.29 ± 0.28. At 10 PFU per cell, values were CHO-al 2, 0.25 ± 0.04; HeLa, 2.82 ± 0.22; and CHO-CAR, 20.64 ± 1.52. At 100 PFU per cell, values were CHO-al 2, 3.13 ± 0.41; HeLa, 53.57 ± 4.10; and CHO-CAR, 210.41 ± 16.38.
38. T. J. Wickham, P. Mathias, D. A. Cheresh, G. R. Nemerow, Cell 73, 309 (1993); M. Bai, L. Campisi, P. Freimuth, J. Virol. 68, 5925 (1994); M. J. Goldman and J. M. Wilson, ibid. 69, 5951 (1995); S. Huang, T. Kamata, Y. Takada, Z. M. Ruggeri, G. R. Nemerow, ibid. 70, 4502 (1996).
39. T. J. Wickham, P. Mathias, D. A. Cheresh, G. R. Nemerow, Cell 73, 309 (1993); M. Bai, L. Campisi, P. Freimuth, J. Virol. 68, 5925 (1994); M. J. Goldman and J. M. Wilson, ibid. 69, 5951 (1995); S. Huang, T. Kamata, Y. Takada, Z. M. Ruggeri, G. R. Nemerow, ibid. 70, 4502 (1996).
40. T. J. Wickham, P. Mathias, D. A. Cheresh, G. R. Nemerow, Cell 73, 309 (1993); M. Bai, L. Campisi, P. Freimuth, J. Virol. 68, 5925 (1994); M. J. Goldman and J. M. Wilson, ibid. 69, 5951 (1995); S. Huang, T. Kamata, Y. Takada, Z. M. Ruggeri, G. R. Nemerow, ibid. 70, 4502 (1996).
41. T. J. Wickham, P. Mathias, D. A. Cheresh, G. R. Nemerow, Cell 73, 309 (1993); M. Bai, L. Campisi, P. Freimuth, J. Virol. 68, 5925 (1994); M. J. Goldman and J. M. Wilson, ibid. 69, 5951 (1995); S. Huang, T. Kamata, Y. Takada, Z. M. Ruggeri, G. R. Nemerow, ibid. 70, 4502 (1996).
42. Single-letter abbreviations for the amino acid residues are as follows: A, Ala; C, Cys; D, Asp; E, Glu; F, Phe; G, Gly; H, His; I, IIe; K, Lys; L, Leu; M, Met; N, Asn; P, Pro; Q, Gln; R, Arg; S, Ser; T, Thr; V, Val; W, Trp; and Y, Tyr.
43. 2+ NTA-Agarose (Qiagen).
44. 2+ NTA-Agarose (Qiagen).
45. G. A. Mayr and P. Freimuth, J. Virol. 71, 412 (1997).
46. J. Brojatsch, J. Naughton, M. M. Rolls, K. Zingler, J. A. T. Young, Cell 87, 845 (1996).
47. We thank W. Lane and T. Addona of the Harvard Microchemistry Facility for expert peptide sequencing; K. Solomon, J. Fingeroth, and D. Sage for advice; J. Kang, M. Chan, and N. Egea for technical assistance; T. Tanaka for providing Ad5.CMV-βgal; and S. King, M. Schneider, A. Goldfeld, W. Marshall, and L. Finkelstein for helpful comments on the manuscript. Large-scale culture of HeLa cells was performed by the Cell Culture Center (Cellex Biosciences, Minneapolis, MN), and DNA sequencing and cell sorting were performed by members of the Dana-Farber Molecular Biology and Flow Cytometry Core Facilities. Supported by grants from NIH (AI35667, AI31628, and CA69703), the American Heart Association (95012650), the Barr Program, the Cystic Fibrosis Foundation (R464), and the Juvenile Diabetes Foundation. J.M.B. is an Established Investigator of the American Heart Association.